Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Herbert Kogler is active.

Publication


Featured researches published by Herbert Kogler.


Chemistry: A European Journal | 2012

Isolation and Structural Elucidation of Armeniaspirols A–C: Potent Antibiotics against Gram‐Positive Pathogens

Cosima Dufour; Joachim Wink; Michael Kurz; Herbert Kogler; Helene Olivan; Serge Sablé; Winfried Heyse; Martin Gerlitz; Luigi Toti; Antje Nußer; Astrid Rey; Cédric Couturier; Armin Bauer; Mark Brönstrup

In an antibiotic lead discovery program, the known strain Streptomyces armeniacus DSM19369 has been found to produce three new natural products when cultivated on a malt-containing medium. The challenging structural elucidation of the isolated compounds was achieved by using three independent methods, that is, chemical degradation followed by NMR spectroscopy, a computer-assisted structure prediction algorithm, and X-ray crystallography. The compounds, named armeniaspirol A-C (2-4), exhibit a compact, hitherto unprecedented chlorinated spiro[4.4]non-8-ene scaffold. Labeling experiments with [1-(13)C] acetate, [1,2-(13)C2] acetate, and [U-(13)C] proline suggest a biosynthesis through a rare two-chain mechanism. Armeniaspirols displayed moderate to high in vitro activities against gram-positive pathogens such as methicillin-resistant S. aureus (MRSA) or vancomycin resistant E. faecium (VRE). As analogue 2 was active in vivo in an MRSA sepsis model, and showed no development of resistance in a serial passaging experiment, it represents a new antibiotic lead structure.


Tetrahedron Letters | 1984

2-(2-pyridyl-)ethyl esters A new carboxyl protecting group in peptide synthesis

Horst Kessler; Günther Becker; Herbert Kogler; Michael Wolff

Abstract 2-(2-pyridyl-)ethyl esters are used as chemically inert, highly selective protecting groups that are removable under mild conditions via a two step procedure.


Tetrahedron Letters | 1991

Butalactin: a new butanolide antibiotic from streptomyces corchorusii

Sugata Chatterjee; Erra K. S. Vijayakumar; Christopher M. M. Franco; Urmila P. Borde; Jurgen Blumbach; B. N. Ganguli; Hans-Wolfram Fehlhaber; Herbert Kogler

Butalactin, (2R*,3S*)-2-(4′,5′-epoxy-hex-2′E-en)oyl-2-hydroxy-3-hydroxymethylbutanolide,(1) is a new antibiotic produced by a Streptomyces sp. HIL Y-86,36923. Butalactin is structurally related to the butyrolactones produced as signal molecules by microorganisms.


Tetrahedron | 1998

MACLAFUNGIN, A NEW ANTIFUNGAL MACROCYCLIC LACTONE FROM ACTINOMYCETE SP. Y-8521050

Triptikumar Mukhopadhyay; Suresh Rudra Nadkarni; M.V. Patel; R. G. Bhat; Kalyanapuram Rajagopalan Desikan; B. N. Ganguli; Richard Helmut Rupp; H.-W. Fehlhaber; Herbert Kogler

Abstract A new antifungal macrocyclic lactone maclafungin, belonging to the oligomycin class has been isolated from an actinomycete sp. Y-8521050. The antibiotic, having a molecular formula of C46H80O12, is active against several fungal species. Its structure was elucidated by analysis of 2D NMR experiments.


The Journal of Antibiotics | 1992

Mersacidin, a new antibiotic from Bacillus fermentation, isolation, purification and chemical characterization

Sukumar Chatterjee; Sugata Chatterjee; Shashikant J. Lad; Mahesh S. Phansalkar; Richard Helmut Rupp; B. N. Ganguli; Hans-Wolfram Fehlhaber; Herbert Kogler


The Journal of Antibiotics | 2000

Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. II. Isolation and structural characterization.

Laszlo Vertesy; Eberhard Ehlers; Herbert Kogler; Michael Kurz; Johannes Meiwes; Gerhard Seibert; Martin Vogel; Peter Hammann


Helvetica Chimica Acta | 1995

Salmycin A–D, Antibiotika aus Streptomyces violaceus, DSM 8286, mit Siderophor-Aminoglycosid-Struktur

Laszlo Vertesy; Werner Aretz; Hans-Wolfram Fehlhaber; Herbert Kogler


Journal of Organic Chemistry | 1994

Balhimycin, a new glycopeptide antibiotic with an unusual hydrated 3-amino-4-oxoaldopyranose sugar moiety

Sugata Chatterjee; Erra K. S. Vijayakumar; Suresh Rudra Nadkarni; M. V. Patel; Jurgen Blumbach; Bimal Naresh Ganguli; H.-W. Fehlhaber; Herbert Kogler; Lsszlo Dr Vertesy


The Journal of Antibiotics | 1992

DEOXYMULUNDOCANDIN -A NEW ECHINOCANDIN TYPE ANTIFUNGAL ANTIBIOTIC

Triptikumar Mukhopadhyay; Kirity Roy; R. G. Bhat; S. N. Sawant; J. Blumbach; B. N. Ganguli; H.-W. Fehlhaber; Herbert Kogler


The Journal of Antibiotics | 1987

Mulundocandin, a new lipopeptide antibiotic. II. Structure elucidation.

Triptikumar Mukhopadhyay; B. N. Ganguli; H.-W. Fehlhaber; Herbert Kogler; L. Vertesy

Collaboration


Dive into the Herbert Kogler's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge